Diseases originating from altered energy homeostasis including obesity, and type 2
diabetes are rapidly increasing worldwide. Research in the last few decades on animal …

Introduction Chronic metabolism-related diseases are challenging clinical problems.
Omentin-1 is mainly expressed in stromal vascular cells of adipose tissue and can also be …

Obesity has been known to be a major risk factor for various types of cancers for several
decades. More recently, the relationship between dysregulated adipokines and cancer …

The molecular mechanisms underlying the cardiotoxicity associated with bevacizumab, a
first‐line immunotherapeutic agent used to treat lung cancer, are not fully understood. Here …

Oncologic patients are subjected to four major treatment types: surgery, radiotherapy,
chemotherapy, and immunotherapy. All nonsurgical forms of cancer management are …

Purpose: Technological advancement in the treatment of cancer together with early
detection and diagnosis have considerably improved the survival of breast cancer patients …

Anticancer agents can cause various side effects, including tissue damages/inflammatory
reactions. Drug-responsive biomarkers are essential for evaluating drug toxicity in disease …

Background Framingham risk score (FRS) is an effective tool for evaluating the 10-year risk
of cardiovascular diseases. However, the sensitivity of FRS for anthracycline-induced …

Background: Chemotherapy-induced cardiotoxicity (CIC) is a significant challenge in cancer
treatment, leading to heart failure and myocardial infarction. With rising cancer survival rates …

Adipose tissue is a complex organ that is increasingly being recognised as the largest
endocrine organ in the body. Adipocytes among multiple cell types of adipose tissue can …